News
The Latest from GKII
-
GKII February Newsletter
News GUPTA-KLINSKY INDIA INSTITUTE, FEBRUARY 15, 2024This newsletter features a letter from the Director, notes on the Public Healthcare Symposium, spotlights on Dr. Benjamin Zaitchik, Damini Agarwal, and Aarna Sanghai, several media mentions and a record number of opportunities.
-
GKII Announces Breakthrough Grant Awardees for Health Data Research
Highlight GUPTA-KLINSKY INDIA INSTITUTE, JANUARY 15, 2024This exciting collaboration with Ashoka University is focused on the field of Health Data Research. Two teams were selected, each with a lead PI from both Johns Hopkins University and Ashoka University. This grant challenge awards $60,000 to each winning proposal for 18 months.
-
Dr. Gigi Gronvall the Awardee of GKII Climate & Health Breakthrough Grant
Highlight GUPTA-KLINSKY INDIA INSTITUTE, JANUARY 13, 2024The Gupta-Klinsky India Institute is excited to announce that Dr. Gigi Gronvall, Associate Professor, Department of Environmental Health and Engineering, at the Johns Hopkins Bloomberg School of Public Health has been selected as the awardee of the Summer 2023 GKII Breakthrough Research Grants Program!
Recent Media Coverage
-
Catching Up with Kunal Parikh
News HOPKINS MEDICINE, JANUARY 1, 2024Kunal Parikh, Ph.D. is no stranger to the Wilmer Eye Institute, Johns Hopkins Medicine community. He first came to Johns Hopkins University in 2012 to start his Ph.D. degree. He gained valuable research experience while working at the Center for Nanomedicine at Wilmer and has collaborated with Wilmer faculty on several initiatives, earning two Catalyst Prizes from the U.S. National Academy of Medicine this year in tandem with Wilmer ophthalmologists.
-
BJ Govt Medical College to check efficacy of ultra-short TB preventive therapy on people with HIV
News INDIAN EXPRESS, DECEMBER 21, 2023The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune. “Evidence from this study will give insights into the adoption of ultra-short 1HP regimens in Indian settings,” said Dr. Vidya Mave, director and leader of BJGMC JHU Clinical Research Site.
-
Why Tuberculosis, an Ancient Disease, Remains a Public Health Threat
Video PUBLIC HEALTH ON CALL, DECEMBER 11, 2023Tuberculosis is one of the oldest diseases on earth—taking more than 1 billion lives throughout history. Dr. Richard Chaisson, director of the Johns Hopkins Center for Tuberculosis Research, talks with Dr. Josh Sharfstein about how TB continues to be a significant threat to global public health, what progress is being made in treatment and prevention, and why research will be needed until the day the last case is treated.